DI COSTANZO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 1.744
EU - Europa 1.344
AS - Asia 437
SA - Sud America 14
OC - Oceania 6
AF - Africa 3
Totale 3.548
Nazione #
US - Stati Uniti d'America 1.736
RU - Federazione Russa 469
PL - Polonia 420
HK - Hong Kong 134
IT - Italia 123
SG - Singapore 123
IE - Irlanda 119
SE - Svezia 100
CN - Cina 76
JO - Giordania 32
IN - India 27
DE - Germania 22
VN - Vietnam 22
FR - Francia 16
ID - Indonesia 16
BR - Brasile 13
FI - Finlandia 13
GB - Regno Unito 13
AT - Austria 10
CA - Canada 8
BE - Belgio 7
CH - Svizzera 7
UA - Ucraina 7
AU - Australia 6
ES - Italia 6
KR - Corea 4
NL - Olanda 4
LT - Lituania 3
CI - Costa d'Avorio 2
HR - Croazia 2
IQ - Iraq 2
AR - Argentina 1
BY - Bielorussia 1
DK - Danimarca 1
GR - Grecia 1
IL - Israele 1
TN - Tunisia 1
Totale 3.548
Città #
Santa Clara 500
Warsaw 420
Fairfield 209
Dublin 119
Chandler 116
Hong Kong 115
Seattle 84
Ashburn 83
Woodbridge 77
Cambridge 68
Singapore 66
Houston 65
Wilmington 65
Lawrence 43
Altamura 42
Ann Arbor 41
Princeton 31
Buffalo 26
Moscow 26
Florence 25
Boston 21
Mumbai 20
Beijing 18
Dong Ket 18
Shanghai 18
Boardman 17
Jakarta 16
New York 16
Medford 12
San Diego 11
Munich 10
Vienna 10
Paris 9
Rome 8
Bern 7
Brussels 7
Pune 7
Redwood City 7
Barcelona 6
Los Angeles 6
Norwalk 6
Toronto 6
Helsinki 5
Melbourne 5
The Dalles 5
Bremen 4
Falls Church 4
Hillsboro 4
Seoul 4
Yubileyny 4
Kent 3
London 3
Lucca 3
Mykolayiv 3
Shenzhen 3
Abidjan 2
Amsterdam 2
Cantu 2
Cinisello Balsamo 2
Conversano 2
Frankfurt am Main 2
Guangzhou 2
Hangzhou 2
Jönköping 2
Laurel 2
Milan 2
Nanjing 2
Newark 2
Ottawa 2
Owings Mills 2
Padova 2
Perugia 2
Phoenix 2
Pietrasanta 2
Pisa 2
Prato 2
Redmond 2
Xian 2
Zagreb 2
Aigaleo 1
Amman 1
Andover 1
Augusta 1
Baghdad 1
Betim 1
Bofete 1
Brejinho 1
Béja 1
Cagliari 1
Changsha 1
Charlotte 1
Criciúma 1
Curitiba 1
Eldorado 1
Feira de Santana 1
Foshan 1
Fuyang 1
Groningen 1
Haifa 1
Incisa 1
Totale 2.596
Nome #
HERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy 274
Gallbladder neuroendocrine neoplasm: a case report and critical evaluation of WHO classification 209
Adjuvant chemotherapy in completely resected gastric cancer: A randomized phase III trial conducted by GOIRC 192
hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma 175
hERG1 and HIF-2α Behave as Biomarkers of Positive Response to Bevacizumab in Metastatic Colorectal Cancer Patients 158
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial 153
Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study 153
KRAS and NRAS mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay: Concordance with standard biopsy and clinical evaluation 149
Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect 148
Circulating tumour cells in colorectal cancer 137
Evaluation of RAS mutational status through BEAMing assay to monitor disease progression of metastatic colorectal cancer: a case report 137
Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study. 133
Physical exercise and eating habits in cancer survivors 131
Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors 124
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 124
Effects of a home based exercise rehabilitation program for cancer survivors 119
Regorafenib also can cause osteonecrosis of the jaw 112
Temperament and character traits associated with health-related quality of life in cancer patients 109
Bevacizumab in non-small cell lung cancer 99
A transcriptomic approach reveals selective ribosomal remodelling in the tumour versus the stromal compartment of metastatic colorectal cancer 97
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer. 96
Quality of life, compliance, safety and effectiveness in fit older metastatic colorectal patients with cancer treated in first-line with chemotherapy plus cetuximab: A restrospective analysis from the ObservEr study 96
Phase II trial of single-agent oral vinorelbine in elderly (> or =70 years) patients with advanced non-small-cell lung cancer and poor performance status 94
A multi-center study on the surgical management of metastatic disease to adrenal glands 93
ITACA-S (Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach) Trial: comparison of a sequential treatment with irinotecan (cpt-11) + 5-fluorouracil (5-FU)/folinic acid (LV) followed by docetaxel and cisplatin versus a 5-FU/LV regimen as postoperative treatment for radically resected gastric cancer 91
Prognostic role of hERG1 Potassium Channels in Neuroendocrine Tumours of the Ileum and Pancreas 76
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme 69
Phase II study of 5-FU plus 6-S-leucovorin (6S-LV) in advanced colorectal cancer 67
Totale 3.615
Categoria #
all - tutte 11.153
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.153


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020111 0 0 0 0 0 0 0 0 0 33 69 9
2020/2021540 45 39 21 82 26 53 39 40 53 83 32 27
2021/2022224 8 17 21 8 5 15 5 15 19 13 31 67
2022/2023608 57 131 33 27 38 110 76 36 68 5 15 12
2023/2024225 3 19 28 12 10 50 15 47 2 16 12 11
2024/20251.394 45 151 79 285 437 206 22 66 75 28 0 0
Totale 3.615